ABSTRACT
This article presents clinical case of external auditory canal osteoma and postoperative management of this patients. In this publication the etiology of this pathology, as well as the clinical manifestations that accompany this pathological condition are described. We present a literature review and our own experience of treatment this group of patients.
Subject(s)
Osteoma , Pharmaceutical Preparations , Anti-Bacterial Agents , Ear Canal/surgery , Humans , Postoperative PeriodABSTRACT
THE PURPOSE OF THE WORK: Is to study the efficacy of treatment of exacerbation of chronic tubotympanic purulent otitis media with Otofa drug with the active substance Rifamycin. MATERIAL AND METHODS: Performed a retrospective analysis of 37 medical histories of patients who applied to the otorhinolaryngology clinic with a diagnosis of exacerbation of chronic purulent tubotympanic otitis media in the period from January 2019 to December 2019. RESULTS: Noted relief of symptoms such as throbbing noise and pain in patients receiving the topical Otofa drug (active ingredient Rifamycin) by the 3th day of therapy. Otofa also reduced otorrhea by the 5th day of therapy. CONCLUSION: The study showed the high clinical efficacy of Otofa ear drops containing the Rifamycin antibiotic.
Subject(s)
Otitis Media, Suppurative , Otitis Media , Anti-Bacterial Agents , Chronic Disease , Conservative Treatment , Humans , Retrospective Studies , Treatment OutcomeABSTRACT
AIM: This multicenter study was focused on the identification of the microorganisms inhabiting the maxillary sinus and middle nasal meatus in chronic rhinosinusitis. METHODOLOGY: 112 middle meatus swabs and 112 maxillary sinus aspirates from 103 patients were available for culture. RESULTS: A total of 244 strains of microorganisms representing more than 50 families were identified in the maxillary sinus and middle nasal meatus (164 and 80, respectively). These included 154 (63.0%) strains of aerobic bacteria from 32 species and 90 (37.0%) strains of anaerobic bacteria from 23 species. Aerobes were more common than anaerobes in both the nasal cavity (78.7% vs. 21.3%) and in the maxillary sinus (55.2% vs. 44.8%). Species of Streptococci (28.8%) and Prevotella (17.8%) were the most common findings in the maxillary sinus aspirates. S. pneumonia, H. influenza, and S. aureus were relatively rare, and found in only 6.7%, 5.4%, and 8.9% of the samples, respectively. CONCLUSIONS: The results obtained suggest that common upper airway pathogens do not play a major role in the pathogenesis of chronic rhinosinusitis. The microbiome of inflamed sinonasal mucosa is extremely diverse and involves exotic species of bacteria that, to date, have not been considered as potential inhabitants of the paranasal sinuses.
Subject(s)
Maxillary Sinus/microbiology , Maxillary Sinusitis/microbiology , Microbiota , Adolescent , Adult , Aged , Chronic Disease , Drug Resistance, Multiple, Bacterial , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Penicillin Resistance , Prospective Studies , Young AdultABSTRACT
The authors repot two cases of successful treatment of external granulation otitis. Taken together, the difficulties encountered in diagnostics of this condition, concomitant disorders aggravating pathological changes in the ear, and the malignant clinical course of the disease hamper the adequate management of external granulation otitis.
Subject(s)
Otitis Externa , Humans , Otitis Externa/therapyABSTRACT
The authors report their original observations of rare and difficultto diagnose atypical localization of the petrosquamosal venous sinusis in the patients presenting with chronic suppurative otitis media. Such localization of this sinus was shown to hamper surgical interventions for sanative treatment.
